70 results
Page 3 of 4
424B7
3x4lgg6
5 May 22
Prospectus with selling stockholder info
12:00am
6-K
EX-99.1
knghrpwjtpviy
14 Apr 22
Current report (foreign)
4:11pm
F-3ASR
n2d o6ugjr8iwtz5
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
6-K
EX-99.1
cg5fj4 w7g2
4 Apr 22
European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
c5odlvmh8q115
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.1
a1u76v09itxc
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
5zxmi5dc
7 Dec 21
Immunocore announces initial Phase 1 data of ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:10pm
6-K
EX-99.2
kschk3127yf4
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.3
iay2 3m45kze6
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
2ve90ptsql6agtht
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
mpunu
24 Aug 21
Current report (foreign)
4:33pm
6-K
EX-99.1
nkyac72lmz5a7wdz mum
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.2
xpdgr97o2
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
6u4h9q58
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
sqf61wbb
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.2
tz2v1
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.1
kbstaoeqhq k5
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
20-F
EX-2.2
higoh
25 Mar 21
Annual report (foreign)
7:01am
20-F
zdjrrhkr1he
25 Mar 21
Annual report (foreign)
7:01am